Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at the use of the CA125 blood test to help monitor women with advanced ovarian cancer

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at whether the CA125 blood test was a reliable way to measure if new treatments for ovarian cancer were working or not. This trial was supported by Cancer Research UK.

The trial was for women who had

  • Ovarian cancer

  • Primary peritoneal cancer

  • Fallopian tube cancer

These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all of these.

Recruitment start: 1 December 2003

Recruitment end: 27 November 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Gordon Rustin

Supported by

Cancer Research UK

East and North Hertfordshire NHS Trust

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUKE/04/014.

Last reviewed: 25 Nov 2013

CRUK internal database number: 544

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.